About Deoxyhypusine synthase
Deoxyhypusine synthase (DHPS) is a protein
from Homo sapiens identified by UniProt accession
P49366, 369 residues long.
MolForge cross-references it against 0 known binders and
128 disease associations.
Target properties
| Protein name | Deoxyhypusine synthase |
| UniProt accession | P49366 |
| Gene | DHPS |
| Organism | Homo sapiens |
| Length | 369 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (128)
Diseases linked to this target (Open Targets).
- syndromic intellectual disability · score 0.58
- Global developmental delay · score 0.47
- Intellectual disability · score 0.46
- Seizure · score 0.46
- Atypical behavior · score 0.46
- Abnormality of head or neck · score 0.46
- EEG abnormality · score 0.46
- Abnormal muscle tone · score 0.46
- neurodegenerative disease · score 0.46
- familial hypercholesterolemia · score 0.44
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P49366-F1 | alphafold | PREDICTED | 94.08 | — |
Amino-acid sequence (369 residues)
MEGSLEREAP AGALAAVLKH SSTLPPESTQ VRGYDFNRGV NYRALLEAFG TTGFQATNFG RAVQQVNAMI EKKLEPLSQD EDQHADLTQS RRPLTSCTIF LGYTSNLISS GIRETIRYLV QHNMVDVLVT TAGGVEEDLI KCLAPTYLGE FSLRGKELRE NGINRIGNLL VPNENYCKFE DWLMPILDQM VMEQNTEGVK WTPSKMIARL GKEINNPESV YYWAQKNHIP VFSPALTDGS LGDMIFFHSY KNPGLVLDIV EDLRLINTQA IFAKCTGMII LGGGVVKHHI ANANLMRNGA DYAVYINTAQ EFDGSDSGAR PDEAVSWGKI RVDAQPVKVY ADASLVFPLL VAETFAQKMD AFMHEKNED
Explore Deoxyhypusine synthase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets